¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Haemorrhagic disorder due to circulation anticoagulants"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® systemic circulation ÇÑ±Û Ã¼¼øÈ¯
¼³¸í   
  ¿Þ½É½Ç¿¡¼­ ½Åü¸¦ µ¹¾Æ ¿À¸¥½É¹æ±îÁöÀÇ ¼øÈ¯À» ÀǹÌÇϸç, ¿Þ½É½Ç ¡æ ´ëµ¿¸Æ ¡æ µ¿¸Æ ¡æ ¸ð¼¼Ç÷°ü ¡æ Á¤¸Æ ¡æ ´ëÁ¤¸Æ ¡æ ¿À¸¥½É¹æÀǠȸ·Î¸¦ ¼øÈ¯ÇÑ´Ù.
¿µ¹® extracorporeal circulation ÇÑ±Û Ã¼¿Ü¼øÈ¯, ¸ö¹Û¼øÈ¯
¼³¸í   
  Ã¼¿ÜÀÇ ÀΰøÈ¸·Î¸¦ µû¶ó ÀÌ·ç¾îÁö´Â ¼øÈ¯¹ý. Ç÷°ü³»¿¡ »ðÀÔÇÑ Æ©ºê¸¦ ÅëÇÏ¿© Ç÷¾×À» Àϴܠü¿Ü·Î ³»º¸³»¼­, ÆßÇÁ¿¡ ÀÇÇÏ¿© ¿¬¼ÓÇÏ¿© ÀçÂ÷ Ã¼³»¿¡ µÇµ¹¸®´Â ¼øÈ¯À» Ã¼¿Ü¼øÈ¯À̶ó°í ÇÑ´Ù. ¿©·¯ °¡ÁöÀÇ ¸ñÀûÀ» À§ÇÏ¿© »ç¿ëµÇ¸ç, ¿©·¯ °¡ÁöÀÇ ¹æ½ÄÀÌ ÀÖ´Ù. °¡À堳θ® »ç¿ëµÇ°í ±âº»À¸·Î µÇ¾î Àִ °ÍÀº, Àΰø½ÉÆó¿¡ ÀÇÇѠü¿Ü¼øÈ¯À¸·Î »ó-ÇÏ´ëÁ¤¸Æ¿¡ »ðÀÔÇÑ »ð°üÀ» ÅëÇÏ¿© ½ÉÀåÀ¸·Î µÇµ¹¾Æ°¡´Â Á¤¸ÆÇ÷À» Ã¼¿Ü¿¡ Àִ »ê¼ÒÈ­ÀåÄ¡·Î À̲ø¾î¼­ »ê¼Ò¸¦ °¡ÇÑ ÈÄ, ÆßÇÁ¿¡ ÀÇÇÏ¿© µ¿¸Æ³»·Î º¸³»´Â ¹æ½ÄÀ¸·Î ½ÉÀåÀ¸·ÎÀǠȯ·ùÇ÷ÀÇ ÀüºÎ¸¦ »ê¼ÒÈ­ÀåÄ¡·Î À̲ô´Â °æ¿ì¸¦ ¿ÏÀüü¿Ü¼øÈ¯, ÀϺκи¸À» À̲ô´Â °æ¿ì¸¦ ºÎºÐü¿Ü¼øÈ¯À̶ó°í ÇÑ´Ù. À̿ܿ¡ Á½ɵθ§±æ¹ý, ¿ì½ÉµÎ¸§±æ¹ý, ½ÅüÀÇ ÀϺκи¸ÀǠü¿Ü¼øÈ¯, º¸Á¶¼øÈ¯µîÀÌ ÀÖ´Ù.
¿µ¹® pulmonary circulation ÇÑ±Û Æó¼øÈ¯
¼³¸í   
  Àü½Å¼øÈ¯À» °ÅÄ£ »ê¼ÒºÐ¾ÐÀÌ ³·Àº Á¤¸ÆÇ÷ÀÌ ¿À¸¥½É¹æÀ¸·Î µé¾î¿Í ¿À¸¥½É½ÇÀ» °ÅÃÄ Æóµ¿¸ÆÀ» ÅëÇÏ¿© Æó·Î °¡¼­ °¡½º ±³È¯À» ÇÑ ÈÄ, »ê¼ÒºÐ¾ÐÀÌ ³ôÀº µ¿¸ÆÇ÷ÀÌ µÇ¾î ÆóÁ¤¸ÆÀ» Å¸°í ´Ù½Ã Á½ɹæÀ¸·Î µ¹¾Æ¿À´Â Ç÷¾×ÀÇ ¼øÈ¯°úÁ¤À» À̸£´Â ¸»ÀÌ´Ù.
¿µ¹® obsessive-compulsive disorder ÇÑ±Û °­¹Ú¹ÝÀÀ¼º Àå¾Ö
¼³¸í   
  °­¹Ú»ç°í(obsession)Àº ¹Ýº¹µÇ´Â »ç°í¸¦ ¸»Çϸç, °­¹ÚÇàÀ§(compulsion)´Â ¹Ýº¹µÇ´Â ÇൿÀ» ¸»ÇÑ´Ù. Áݺ¹µÇ´Â »ç°í¿¡ µû¶ó ¹Ýº¹ÀûÀΠÇൿÀ» ¼öÇàÇϴ Àå¾Ö¸¦ ¸»ÇÑ´Ù. À̶§ ¹Ýº¹ÀûÀΠ»ç°í´Â ÀÌ·ÐÀûÀ¸·Î ÀÌÇØµÇÁö ¾Ê´Â °æ¿ì°¡ ¸¹°í, º»Àεµ ÀÌ·± »ç°í°¡ ÀÌÇØµÇÁö ¾Ê´Â´Ù´Â »ç½ÇÀ» ¾Ë°í °íÄ¡·Á°í ÇÏÁö¸¸, Àß µÇÁö ¾Ê´Â´Ù. ¶ÇÇÑ °è¼ÓÀûÀ¸·Î ÀÌ·± »ç°í¿¡ µû¸¥ ¹Ýº¹ÀûÀΠÇൿÀ» Çϸç, ÀÌ·± ÇൿÀ» ¼öÇàÄ¡ ¾ÊÀ» ½Ã, º»ÀÎÀÇ ÀÇÁö¿Í ¹«°üÇϰԠ¸÷½Ã ºÒ¾ÈÇØÇϰí, ÃÊÁ¶ÇØÇÑ´Ù.
¿µ¹® panic disorder ÇÑ±Û °øÈ²Àå¾Ö
¼³¸í   
  ¹Ýº¹µÇ´Â °øÈ²¹ßÀÛ(panic attack: °©ÀÛ½º·± °øÆ÷»óÅÂÀÇ ¹ßº´)°ú ½Å°æ°ú¹ÎÀ» ³ªÅ¸³»´Â °æ¿ì¸¦ ¸»ÇÔ. °øÈ²¹ßÀÛÀº ´Üµ¶À¸·Î ÀϾ±âº¸´Ù´Â ¿À·£ ±äÀå»óÅ¿¡¼­ ÁÖ±âÀûÀ¸·Î ÀϾ´Â Çö»óÀ¸·Î º¸ÀδÙ. °øÈ²¹ßÀÛÀÇ Áõ»óÀº ±Þ°ÝÇÑ ÀÚÀ²½Å°æÀÚ±ØÁõ»óÀ¸·Î È£Èí°ï¶õ, ½ÉÀå¹Úµ¿Ç×Áø, ÈäºÎÅëÁõ, ÈäºÎ¾Ð¹Ú°¨, Áú½Ä°¨, Çö±âÁõ, ºÒ¾ÈÁ¤ÇÑ ´À³¦ µîÀÌ´Ù. ´ë°³ °©ÀÚ±â ÀϾ ¼öºÐµ¿¾È Áö¼ÓÇß´Ù°¡ ¼Ò½ÇµÇ´Â °ÍÀÌ º¸ÅëÀÌ´Ù. µå¹°°Ô´Â ¼ö½Ã°£ Áö¼ÓµÇ±âµµ ÇÑ´Ù. °øÈ²¹ßÀÛÀº ÁÖ±âÀûÀ¸·Î ¹Ýº¹µÇ¸é¼­ ¸¸¼ºÈ­Çϴ °æÇâÀÌ ¸¹´Ù. ½Å°æ°ú¹ÎÀº °øÈ²¹ßÀÛÀÌ ¾ø´Â ½Ã±âÀÇ Áõ»óÀÌ´Ù. °¨´çŰ ¾î·Á¿î °øÈ²¹ßÀÛ¿¡ ´ëÇÑ ¿¹±âºÒ¾È(±× ÀÏÀÌ ÀϾÁö ¾ÊÀ»±î Çϴ ´À³¦ ¶§¹®¿¡ ¿À´Â ºÒ¾È)ÀÌ ÀÖ°í ±× ¶§¹®¿¡ Á¶½É½º·¯¿öÁö°í ÁÖÀ§¸¦ »ìÇǴ Åµµµµ ³ªÅ¸³ª¼­ ½Å°æÀº ±Øµµ·Î ³¯Ä«·Î¿öÁø´Ù. °øÆ÷Àå¾Ö¿¡¼­µµ ÀÌ·± °øÈ²¹ßÀÛÀÌ ¿Ã ¼ö ÀÖÀ¸³ª, ÀÌ °æ¿ì´Â Æ¯º°ÇÑ ´ë»óÀ̳ª »óȲÀÌ Àִ °Í¿¡ ¹ÝÇØ °øÈ²Àå¾Ö´Â ÀÌ·± Æ¯º°ÇÑ »ç°Ç¾øÀÌ ÁÖ±âÀûÀ¸·Î ¹ß»ýÇÑ´Ù. Ä¡·á´Â Ç׺ҾÈÁ¦¿Í ¶§·Î´Â Ç׿ì¿ïÁ¦¸¦ »ç¿ëÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arm-to-retina circulation time
    ÆÈ¸Á¸·¼øÈ¯½Ã°£
  • circulation
    ¼øÈ¯
  • circulation time
    ¼øÈ¯½Ã°£
  • collateral circulation
    °ç¼øÈ¯
  • compensatory circulation
    º¸»ó¼øÈ¯
  • coronary circulation
    °ü»óµ¿¸Æ¼øÈ¯, ½ÉÀ嵿¸Æ¼øÈ¯
  • cross circulation
    ±³Â÷¼øÈ¯
  • extracorporeal circulation
    ü¿Ü¼øÈ¯, ¸ö¹Û¼øÈ¯
  • enterohepatic circulation
    âÀÚ°£¼øÈ¯, Àå°£¼øÈ¯
  • fetal circulation
    žƼøÈ¯
  • omphalomesenteric circulation
    ¹è²ÅâÀÚ°£¸·¼øÈ¯
  • placental circulation
    ŹݼøÈ¯
  • portal circulation
    ¹®¸Æ¼øÈ¯
  • systemic circulation
    ¿Â¸ö¼øÈ¯, ü¼øÈ¯
  • vitelline circulation
    ³­È²¼øÈ¯
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circulation
    ¼øÈ¯
  • collateral circulation
    °ç¼øÈ¯
  • portal circulation
    ¹®¸Æ¼øÈ¯
  • systemic circulation
    ¿Â¸ö¼øÈ¯, ü¼øÈ¯
  • disorder
    Àå¾Ö, Áúȯ
  • adjustment disorder
    ÀûÀÀÀå¾Ö
  • affective disorder
    Á¤µ¿Àå¾Ö
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • articulation disorder
    ÀÔ¼Ò¸®Àå¾Ö, ¹ßÀ½Àå¾Ö
  • attention-deficit hyperactivity disorder
    ÁÖÀǷ°áÇ̰ú´ÙȰµ¿Àå¾Ö
  • autistic disorder
    ÀÚÆóÀå¾Ö, ÀÚÆóº´
  • behavior disorder
    ÇൿÀå¾Ö
  • body dysmorphic disorder
    ½ÅüÃßÇüÀå¾Ö
  • childhood anxiety disorder
    ¼Ò¾ÆºÒ¾ÈÀå¾Ö
  • cognitive disorder
    ÀÎÁöÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arm-to-retina circulation time
    ÆÈ¸Á¸·¼øÈ¯½Ã°£
  • circulation
    ¼øÈ¯
  • collateral circulation
    °ç¼øÈ¯
  • compensatory circulation
    (¢¡collateral circulation) °ç¼øÈ¯
  • coronary circulation
    ½ÉÀ嵿¸Æ¼øÈ¯
  • cross circulation
    ±³Â÷¼øÈ¯
  • enterohepatic circulation
    âÀÚ°£¼øÈ¯
  • extracorporeal circulation
    ü¿Ü¼øÈ¯, ¸ö¹Û¼øÈ¯
  • fetal circulation
    žƼøÈ¯
  • omphalomesenteric circulation
    (¢¡vitelline circulation) ³­È²¼øÈ¯
  • placental circulation
    ŹݼøÈ¯
  • portal circulation
    ¹®¸Æ¼øÈ¯
  • systemic circulation
    ¿Â¸ö¼øÈ¯, ü¼øÈ¯
  • vitelline circulation
    ³­È²¼øÈ¯
  • adhesion deficiency disorder
    À¯Âø°áÇÌÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fetal circulation
    žƼøÈ¯(÷Ãä®âàü»)
  • Intestinal circulation
    Àå°ü¼øÈ¯(íóηâàü»)
  • Lymphatic circulation
    ¸²ÇÁ¼øÈ¯(¡­âàü»)
  • arm-to-retina circulation time
    ÆÈ¸Á¸·¼øÈ¯½Ã°£, ¿Ï-¸Á¸·¼øÈ¯½Ã°£
  • artificial circulation
    Àΰø¼øÈ¯.
  • general circulation
    ´ë¼øÈ¯(ÓÞâàü»).
  • general circulation
    ´ë¼øÈ¯.
  • grater circulation
    ´ë¼øÈ¯.
  • greater circulation
    ´ë¼øÈ¯(ÓÞâàü»).
  • hypophysioportal circulation
    ³úÇϼöü¹®¸Æ¼øÈ¯, Çϼöü¹®¼øÈ¯(¡­Ú¦âàü»).
  • hypothalamohypophyseal portal circulation
    ½Ã»óÇϺγúÇϼöü¹®¸Æ¼øÈ¯.
  • placental circulation
    ŹݼøÈ¯(¡­âàü»).
  • portal circulation
    ¹®¸Æ¼øÈ¯(¡­âàü»).
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£(¡­ãÁÊà).
  • Body dysmorphic disorder
    ½ÅüÀÌÇüÀå¾Ö(º´)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • jaundice due to biliary stasis
    ´ãÁó¿ïü¼º Ȳ´Þ(ÓÅñðê¦ôòàõüÜÓ¸).
  • allantoic circulation
    ¿ä¸·¼øÈ¯(èñدâàü»).
  • arm-to-retina circulation time
    ÆÈ¸Á¸·¼øÈ¯½Ã°£, ¿Ï-¸Á¸·¼øÈ¯½Ã°£
  • artificial circulation
    Àΰø¼øÈ¯.
  • assisted circulation
    º¸Á¶¼øÈ¯(ÜÍð¾âàü»).
  • blood circulation
    Ç÷¾×¼øÈ¯(úìäûâàü»).
  • cerebral circulation
    ³ú¼øÈ¯(Òàâàü»).
  • chorionic circulation
    À¶¸ð¼øÈ¯, À¶¸ð(¸·)Ç÷Çà(¡­úìú¼).
  • circulation
    ¼øÈ¯, Ç÷Çà(úìú¼)
  • circulation
    ¼øÈ¯
  • circulation time
    ¼øÈ¯ ½Ã°£(âàü»ãÁÊà)
  • collateral circulation
    ÃøºÎ¼øÈ¯(¡­âàü»), ÃøºÎÇ÷Çà(¡­úìú¼)
  • collateral circulation
    ÃøºÎ¼øÈ¯
  • compensatory circulation
    ´ë»ó¼º ¼øÈ¯(ÓÛßÁâàü»)(¡­.
  • coronary circulation
    °ü(»ó)(µ¿¸Æ)¼øÈ¯(¡­ÔÑØæâàü»).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Embryonic circulation
    žƼøÈ¯
    [¿¾ ¿ë¾î] žƼøÈ¯
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • collateral circulation
    ÃøºÎ¼øÈ¯, ÃøºÎÇ÷Çà
  • derivative circulation
    À¯µµ¼øÈ¯
  • fetal circulation
    žƼøÈ¯, žÆÇ÷Çà
  • hypothalamohypophyseal portal circulation
    ½Ã»óÇϺγúÇϼöü¹®¸Æ¼øÈ¯
  • portal circulation
    ¹®¸Æ¼øÈ¯
  • pulmonary circulation
    Æó¼øÈ¯
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£
  • behavior disorder
    ÇൿÁúȯ
  • blood disorder
    Ç÷¾×Áúȯ
  • convulsive disorder
    °æ·Ã¼ºÀå¾Ö
  • disorder
    Àå¾Ö, Áúº´
  • hypothalamic disorder
    ½Ã»óÇϺÎÁúȯ
  • metabolic disorder
    ´ë»çÀå¾Ö
  • neurological disorder
    ½Å°æ°èÀå¾Ö
  • neurotic disorder
    ½Ã°æÁõÀûÀå¾Ö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
ADCC acute disorder of cerebral circulation; antibody-dependent cell-mediated cytotoxicity
d/t due to
dt due to; dystonic
DUE drug use evaluation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OA Oral anticoagulants
DUE DNA unwinding element
DUE Drug usage evaluation
ECC extra corporal circulation
EC Extracorporeal circulation
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • D68.3
    Haemorrhagic disorder due to circulation anticoagulants
    ¼øÈ¯¼º Ç×ÀÀ°í¹°¿¡ ÀÇÇÑ ÃâÇ÷¼º Àå¾Ö
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • jaundice due to biliary stasis
    ´ãÁó ¿ïü¼º Ȳ´Þ
  • allantoic circulation
    ¿ä¸· ¼øÈ¯
  • arm-to-retina circulation time
    ÆÈ ¸Á¸· ¼øÈ¯ ½Ã°£
  • artificial circulation
    Àΰø ¼øÈ¯
  • blood circulation
    Ç÷¾× ¼øÈ¯
    Á½ɽǿ¡¼­ µ¿¸ÆÀ¸·Î ¾ÐÃâµÈ Ç÷¾×Àº ¸ð¼¼Ç÷°üÀ» °ÅÃļ­ Á¤¸ÆÀ¸·Î ³ª¿À°í ¿ì½É¹æÀ¸·Î ȯ·ùÇØ À̰÷¿¡¼­ ¿ì½É½Ç·Î µé¾î°£´Ù. ¿ì½É½ÇÀÇ ¼öÃàÀ¸·Î Æóµ¿¸ÆÀ¸·Î º¸³»Á® Æó ¸ð¼¼°üÀ» °ÅÃļ­ Æó Á¤¸Æ¿¡¼­ Á½ɹæÀ¸·Î µé¾î°¡°í ´Ù½Ã Á½ɽǷΠµé¾î°¡ ¸ö ¾ÈÀ» ÇѹÙÄû µ·´Ù.
  • circulation of lymph
    ¸²ÇÁ ¼øÈ¯
    ¸²ÇÁ°¡ Á¶Á÷ »çÀÌ¿¡¼­ ¸ð¼¼¸²ÇÁ °ü¿¡ µé¾î°¡°í ¸²ÇÁ°üÀ» Áö³ª Á¤¸ÆÀ¸·Î µé¾î°¡´Â °è·Î ¸²ÇÁ°ü°è´Â Á¶Á÷ »çÀÌ¿¡¼­ ½ÃÀÛÇÏ¿© Á¶Á÷ °£±Ø¿¡ ÀÖ´Â Á¶Á÷¾×ÀÌ ÀϺΠ¸²ÇÁ¸ð¼¼°ü¿¡ µé¾î°¡ ¸²ÇÁ°¡ µÈ´Ù. ¸²ÇÁ°ü ¼Ó¿¡´Â ÆÇÀÌ ¿©·¯ °³ Á¸ÀçÇÏ°í ±ÙÀ°ÀÌ ¼öÃàÇÏ¸é ±× ¼Ó¿¡ ÀÖ´Â ¸²ÇÁ°üÀº ¾ÐÂøµÇ¸ç ¸²ÇÁ´Â ÇÑ ¹æÇâÀ¸·Î ¹Ð·Á¼­ È帥´Ù. ¸²ÇÁ°ü°è ±ºµ¥±ºµ¥¿¡ ¸²ÇÁÀýÀÌ ÀÖ°í °¢ ¸²ÇÁÀý¿¡´Â ¸»ÃÊÃøÀ¸·ÎºÎÅÍ ¸î °³ÀÇ ¸²ÇÁ°üÀÌ µé¾î°¡ ÀÖÀ¸¸ç 1¡­2°³ÀÇ ¸²ÇÁ°üÀÌ ³ª¿Í ÀÖ´Ù. ÀÌ·¸°Ô ÇÏ¿© Á¡Â÷ ±½¾îÁø ¸²ÇÁ°üÀº ¸¶Áö¸·¿¡´Â Á¤¸Æ°¢ ºÎ±Ù¿¡¼­ Á¤¸Æ°è¿Í ÇÕÄ£´Ù. °³±¸¸® µîÀÇ ¸²ÇÁ°èÅëÀº Æ÷À¯·ùÀÇ °Í°ú ¸Å¿ì ´Ù¸£´Ù. À̰ÍÀº °üÀÌ ¾Æ´Ï°í ³¶»óÀ» ÀÌ·ç°í ÀÖ¾î ¸²ÇÁ³¶À̶ó°í ÇÑ´Ù. °³±¸¸®ÀÇ °æ¿ì´Â ÇǺΠ¹Ø¿¡ ¸²ÇÁ³¶ÀÌ ÀÖÀ¸¸ç, µîÀÇ »óºÎ¿Í ÇϺο¡ Á¿ì 2°³¾¿ ÀÖ´Â ¸²ÇÁ ½ÉÀåÀÌ ¸²ÇÁ¸¦ ¿îµ¿½Ã۰í ÀÖ´Ù.
  • collateral circulation test
    ÃøºÎ ¼øÈ¯ ½ÃÇè
  • cutaneous circulation
    ÇǺΠ¼øÈ¯
  • derivative circulation
    À¯µµ ¼øÈ¯
  • entero-hepatic circulation
    °£Àå³» ¼øÈ¯
  • hypophysioportal circulation
    ³úÇϼöü ¹®¸Æ ¼øÈ¯, Çϼöü ¹® ¼øÈ¯
  • hypothalamohypophyseal portal circulation
    ½Ã»ó ÇϺΠ³úÇϼöü ¹®¸Æ ¼øÈ¯
  • internal carotid circulation
    ³»°æ µ¿¸Æ ¼øÈ¯
  • juxtamedullary circulation
    ¹æ¼öÁú ¼øÈ¯
  • lesser circulation
    ¼Ò ¼øÈ¯
    Á¤¸Æ Ç÷°üÀ» ¿ì½É½Ç·ÎºÎÅÍ Æó·Î ¿î¹ÝÇÏ¿© »ê¼Ò Æ÷È­ Ç÷¾×À» Á½ɹæÀ¸·Î µ¹·Áº¸³»´Â ¼øÈ¯.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
lupus anticoagulants Lupus anticoagulants are a common cause of a prolonged activated partial thromboplastin time (APTT) which is corrected by the addition of platelet -rich plasma (or phospholipids) and not by platelet-poor plasma. The methods of choice for detection of lupus anticoagulants are the kaolin clotting time using the rabbit brain neutralisation procedure and the dilute Russell viper venom test (dRVVT).
Current data suggest that lupus anticoagulants and antibodies to negatively charged phospholipids (cardiolipin, phosphatidylserine, phosphatidic acid and phosphatidylinositol) are risk factors for arterial and venous thrombosis and for recurrent abortions in populations of patients which are distinct but overlapping. Drug-induced lupus anticoagulants are also associated with increased risk of thrombosis. Current testing for lupus anticoagulants and phospholipid antibodies (cardiolipin plus phosphatidylserine) may be useful for assessing risk in patients with systemic lupus erythematosus. Some data indicate that lupus anticoagulants assays are more reliable predictors of thrombosis, foetal loss and thrombocytopenia than are cardiolipin antibody (ACA) assays. Although the technology is in many ways more reliable, the rush to describe associations of lupus anticoagulants with various disorders has been much less scientifically unseemly than has been that of ACAs with their bewildering variety of clinical associations. The contribution of one serious study must, it seems, render tolerable the excess of trivia recently published in this area.
See also cardiolipin antibodies and phospholipid antibodies.
(05 Mar 2000)
due date The estimated calendar date when a baby will be born, the date the baby is due to be born. It is also called the estimated date of confinement (EDC).
(12 Dec 1998)
dystonia, focal, due to blepharospasm The second most common focal dystonia, the involuntary, forcible closure of the eyelids. The first symptoms may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal.
(12 Dec 1998)
dystonia, focal, due to torticollis Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward.
(12 Dec 1998)
thrombotic disease due to protein c deficiency Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal.
(12 Dec 1998)
assisted circulation Pumping that aids the natural activity of the heart.
(12 Dec 1998)
blood circulation The course of the blood from the heart through the arteries, capillaries, and veins back again to the heart.
(05 Mar 2000)
blood circulation time Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points.
(12 Dec 1998)
capillary circulation The course of the blood through the capillaries.
(05 Mar 2000)
renal circulation The circulation of the blood through the vessels of the kidney.
(12 Dec 1998)
respiratory circulation The mechanisms of pulmonary circulation coordinated with the heart and systemic circulation. It involves the flow or interruption of the flow of blood to the lungs as it affects respiration. Pulmonary circulation, a circulatory concept, emphasizes the passage of blood from the right to the left heart through the lungs. Respiratory circulation coordinates this with heart action, systemic circulation, and breathing.
(12 Dec 1998)
cerebrovascular circulation The circulation of blood through the vessels of the brain.
(12 Dec 1998)
greater circulation The circulation of blood through the arteries, capillaries, and veins of the general system, from the left ventricle to the right atrium.
Synonym: greater circulation.
(05 Mar 2000)
persistent foetal circulation syndrome <syndrome> A syndrome of persistent pulmonary hypertension in the newborn infant, without demonstrable cardiac disease. It is characterised by cyanosis and acidosis, severe pulmonary vasoconstriction, hypertrophy of pulmonary arterial muscle, and elevated pulmonary vascular resistance, with resultant right-to-left shunting of blood through a patent ductus arteriosus and at times a patent foramen ovale.
(12 Dec 1998)
circulation <physiology> Movement in a regular or circuitous course, as the movement of the blood through the heart and blood vessels.
Origin: L. Circulatio
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • disorder
    ºÎÁ¶È­
  • disorder
    ¹«Áú¼­;È¥¶õ;È¥¶õ½ÃŰ´Ù;º´µé°ÔÇÏ´Ù
  • mental disorder
    Á¤½Å Âø¶õ 6
  • due
    Á¤´çÇÑ,-¿¡ ÀÇÇÑ,Á¤È®È÷
  • due
    ÀÀ´çÄ¡·¯¾ßÇÒ;ÀÀ´ç;¿¡ µ¹¿©¾ßÇÒ;ÇÒ ¿¹Á¤ÀÎ;´ç¿¬ÇÒ;Á¤½ÄÀ¸·Î;¶§°¡ ¿À¸é;¸¶¶¥È÷;¼¼±Ý
  • due bill
    Â÷¿ë Áõ¼­
  • due date
    ¾îÀ½ÀÇ ¸¸±âÀÏ
  • due process
    (¹ý)Á¤´çÇÑ ¹ýÀÇ ÀýÂ÷(¹Ì±¹ Çå¹ý Á¦ 5Á¶,Á¦ 14Á¶)
  • postage due
    ¿ìÆí ¿ä±Ý ºÎÁ·
  • circulation
    À¯Åë
  • circulation
    ¼øÈ¯;À¯Åë;À¯Æ÷;Àü´Þ;¹ßÇàºÎ¼ö;º¸±Þ(ÆÇ¸Å)ºÎ¼ö;(µµ¼­ÀÇ)´ëÃâºÎ¼ö;ÅëÈ­;À¯Åë¾îÀ½
  • circulation director
    (½Å¹®.ÀâÁöÀÇ)ºÎ¼öÈ®Àå´ã´çÀÌ»ç
  • circulation guarantee
    ºÎ¼ö º¸Áõ(±¤°íÁÖ¿¡ ´ëÇÑ)
  • controlled circulation
    (ÀâÁö.½Å¹®ÀÇ)¹«·á ¹èºÎ ºÎ¼ö(ÁõÁ¤,±¤°í ±ÇÀ¯¿ë)
  • currency circulation
    ÅëÈ­ À¯Åë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á